HSJ and controls stratified by timing for CS and parity. by Eva Rydahl (6260771)

Subjects:

Malaria prevalence over the years is presented by age (Fig 3A), sex (Fig 3B), history of fever (Fig 3C), geographical zones (Fig 3D), ITN use (Fig 3E), and elevation (Fig 3F). by Frank Chacky (3446654)

Subjects:

Crude and adjusted odds ratios of malaria prevalence in school children using multilevel mixed-effect logistic regression model in mainland Tanzania, 2015–2023. by Frank Chacky (3446654)

Subjects:

Socio-demographic characteristics of the survey participants 2015–2023. by Frank Chacky (3446654)

Subjects:

A map of Tanzania indicating surveyed schools along with regional and council boundaries was created. by Frank Chacky (3446654)

Subjects:

Malaria infection prevalence across different age groups and survey years is presented. by Frank Chacky (3446654)

Subjects:

S1 Fig - by Frank Chacky (3446654)

Subjects:

Flowchart of the study protocol. by Min Wang (21070)

Subjects:

Subject characteristics (n = 45). by Min Wang (21070)

Subjects:

Effect of Bcl-xL on proteins involved in the apoptotic pathway of MDCK cells. by Jiahao Zheng (807470)

Subjects:

Effect of Bcl-xl on the tumorigenicity of MDCK cells in nude mice. by Jiahao Zheng (807470)

Subjects:

Analysis and comparison of transcriptome data between WT and BY-02 cells. by Jiahao Zheng (807470)

Subjects:

The targeting strategies, qRT-PCR, and western bolt to verify BY-02 cells. by Jiahao Zheng (807470)

Subjects:

Differences in growth, metabolism and migration of BY-02 cells compared with WT cells. by Jiahao Zheng (807470)

Subjects:

Transcriptome analysis. by Jiahao Zheng (807470)

Subjects:

Table 1_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 2_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 3_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 5_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”

Table 4_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx by Fengwang Xue (22245625)

“…Further validation using RCS analysis revealed a robust inverse relationship between PNI scores and ACM, and subgroup analyses revealed no significant interactions.</p>Conclusion<p>Among pneumonia patients receiving glucocorticoid therapy, a decreased PNI was associated with an increased risk of 30-day and 90-day mortality, particularly in those with a PNI < 43.…”